Skip to main content
. 2017 Aug 10;6:e27190. doi: 10.7554/eLife.27190

Figure 9. EphrinB1 involvement in endosome biogenesis.

(A) Time-lapse sequence of ephrinB1-mCherry distribution following explantation. After 5 min, ephrinB1 (eB1) has become enriched at the trailing membrane (white arrows). (B) Co-localization of ephrinB1 with endosomes (top row). Higher magnification (bottom row, i–iii) shows that ephrinB1 is enriched near endosomes (white arrow). (C) Quantification of ephrinB1-mCherry fluorescence intensity relative to mGFP at different plasma membrane domains. Bars indicate S.E. (D) Overexpression of full-length ephrinB1 (eB1FL) in membrane-labelled cells causes aberrant vesicle formation at the entire cell cortex (white arrows). (E) Quantification of vesicle number at the trailing edge of uninjected (control), ephrinB1-morpholino (eB1MO) injected, and eB1FL mRNA-injected cells. (F) Trailing edge membrane tapering during retraction. Uninjected cells show typical recession behaviour (top row), while the rear of eB1MO-injected cells remains blunt (bottom row). (G) Quantification of trailing edge width in uninjected (left) and eB1MO-injected (right) cells. Average rate change is shown (black line). Colours represent individual cells. (H) Morphology of uninjected (left), eB1MO-injected (center), and eB1FL mRNA-injected (right) labelled (mRFP) cells in live explants. Animal is to the top, vegetal to the bottom. For C, E, and G, plots show data sampled from five embryos collected from different egg batches.

Figure 9—source data 1. Quantification of ephrinB1 distribution, effects of ephrinB1 on vesicle number and trailing edge width.
elife-27190-fig9-data1.xlsx (10.7KB, xlsx)
DOI: 10.7554/eLife.27190.034

Figure 9.

Figure 9—figure supplement 1. Mid-sagittal fractures of stage 12 uninjected (left), eB1MO-injected (centre), and eB1FL mRNA-injected (right) gastrulae.

Figure 9—figure supplement 1.

BCF length (red line) and dissociated cells (red arrows) are indicated.
Figure 9—figure supplement 2. Co-localization of ephrinB1 (eB1-mCh) with membrane-label (mGFP) shows that ephrinB1 is dispersed over the entire membrane, but enriched at the trailing edge membrane (yellow arrows), particularly at the rear (blue arrows).

Figure 9—figure supplement 2.

Individual images are shown alongside the merged image. From left to right, the images represent mGFP only, eB1-mCh only, merged composite, a co-localisation rendering showing sites of co-localisation in white (white areas) superimposed on a composite image of mGFP and eB1-mCh, and a co-localisation-only panel, with the composite image removed for clarity.